Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Sexually Transmitted Infections (STIs) Market?
In the past few years, the market size for sexually transmitted infections (STIs) has been expanding swiftly. It is predicted to scale up from $63.69 billion in 2024 to a whopping $71.93 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth during the historic period include behavioral influences, education and awareness initiatives, healthcare accessibility, and the advancement of antibiotics.
What Growth Rate Is Forecasted for the Sexually Transmitted Infections (STIs) Market by 2029?
In the years ahead, the sexually transmitted infections (STIs) market is predicted to experience swift expansion. The anticipated growth rate is 12.0% annually, reaching a market size of $113.38 billion in 2029. Factors contributing to this increase during the forecast period encompass emerging STI strains, vaccination campaigns, telemedicine, at-home testing measures, and equalizing sexual health. The projection period also indicates significant trends such as escalating antimicrobial resistance, pre-exposure prophylaxis (prep), self-management of STIs, and improved sexual education.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Key Companies Are Shaping the Future of the Sexually Transmitted Infections (STIs) Market?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Which Factors Are Driving Demand in the Sexually Transmitted Infections (STIs) Industry?
Growing governmental initiatives aimed at raising awareness about sexually transmitted infections (STIs) are anticipated to fuel the expansion of the STIs market. Such initiatives, formalized through policies or programs, work towards specific goals or issues. Various programs to prevent, manage, and treat STIs are put forth by the government, including public education campaign funding to increase STIs awareness, vaccines for preventing certain STIs, and free or discounted screening and diagnostic services. An illustration of this was seen in April 2023, when the US-based public health division, Springfield-Greene County Health, launched the Disease Intervention Specialist (DIS) programs in collaboration with Missouri Department of Health and Senior Services (Missouri DHSS). This initiative was aimed at countering the escalating spread of STIs within Greene County. The specialists of the DIS program, focusing mainly on syphilis and HIV, would reach out to diagnosed individuals, provide them treatment options, and help pinpoint and educate those who have come in contact, about the infection. Therefore, the growth of the STIs market is being propelled by these increasing government initiatives. A surge in occurrences of unprotected sex is predicted to stimulate the growth of the sexually transmitted infections (STIs) market. The escalating trend of unprotected sex pertains to sexual acts undertaken without the use of preventive measures like condoms, thereby promoting the dissemination of sexually transmitted diseases (STIs). For instance, as highlighted by a 2024 report from the intergovernmental organization, World Health Organization, the proportion of sexually active teenagers using condoms during their most recent coitus fell in 2022, with 61% males and 57% females admitting to using condoms, down from the previous rates of 70% and 63% respectively. Thus, the rise in unprotected sex is a major contributor to the expansion of the STIs market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
How Is the Sexually Transmitted Infections (STIs) Market Segmented by Several Divisions?
The sexually transmitted infections (STIs) market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis
What are the Emerging Market Trends Driving the Growth of the Sexually Transmitted Infections (STIs) Industry?
Prominent players in the Sexually Transmitted Infections (STIs) market are introducing novel products incorporating fluorescent PCR technology to reinforce their competitive standing in the industry. Fluorescent PCR or Polymerase Chain Reaction, a molecular biology technique, helps in identifying and measuring particular DNA sequences in a biological specimen. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a renowned China-based entity providing molecular diagnostic solutions, launched two innovative polymer chain reaction (PCR) kits: Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These kits provide an all-inclusive PCR solution helpful in early diagnoses of sexually transmitted diseases affecting numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit functions as a reagent using fluorescent PCR technology that specifically detects Mycoplasma hominis in male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit has been engineered to detect treponema pallidum nucleic acid in human serum and plasma samples.
Access The Full Report Here:
Which Regions Are Driving Growth in the Sexually Transmitted Infections (STIs) Market?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047
This Report Delivers Insight On:
1. How big is the sexually transmitted infections (stis) market, and how is it changing globally?
2. Who are the major companies in the sexually transmitted infections (stis) market, and how are they performing?
3. What are the key opportunities and risks in the sexually transmitted infections (stis) market right now?
4. Which products or customer segments are growing the most in the sexually transmitted infections (stis) market?
5. What factors are helping or slowing down the growth of the sexually transmitted infections (stis) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model